心房颤动合并慢性心力衰竭患者血浆利钠肽水平变化的研究
被引量:7
摘要
B型利钠肽(BNP)可以在多种心脏病中升高,在心力衰竭(心衰)中升高更为显著,且与疾病的严重程度相关,其作为心衰重要标志物在心衰的诊断、治疗及预后方面均有重要的临床价值,但是BNP水平受多种因素的影响,如年龄、性别、肺栓塞、急性冠脉综合征、心律失常、肾功能不全等。
出处
《天津医药》
CAS
北大核心
2011年第5期465-466,共2页
Tianjin Medical Journal
参考文献8
-
1Raymond I,Groenning BA,Hildebrandt PR,et al.The influence of age,sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population[J].Heart,2003,89(7):745-751.
-
2Wozakowska-Kaplon B,Opolski G,Herman Z,et al.Natriuretic peptides in patients with atrial fibrillation[J].Cardiol J.2008,15(6):525-529.
-
3Rossi A,Enriquez-Sarano M,Burnett JC,et al.Natriuretic peptide levels in atrial fibrillation:a prospective hormonal and Doppler-echoeardiographic study[J].J Am Coll Cardiol,2000,35(5):1256-1262.
-
4Jug B,Sebesljen M,Sabovic M,et al.Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure[J].Wien Klin Wochenschr,2009,121(21-22):700-706.
-
5Luchner A,Stevens TL,Borgeson DD,et al.Differential atrial and ventricular expression of Myocardial BNP during evolution of heart failure[J].Am J Physiol,1998,274(5 Pt 2):H1684-1689.
-
6Silvet H,Young-Xu Y,Walleigh D,et al.Brain natriuretic peptide is elevated in outpatients with atrial fibrillation[J].Am J Cardiol,2003,92(9):l 124-1127.
-
7I noue S,Murakami Y,Sano K,et al.Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation[J].J Card Fail,2000,6(2):92-96.
-
8Tuinenburg A,Brundel B,Van Gelder I,et al.Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation[J].J Cardiovasc Electrophysiol,1999,10(6):827-835.
同被引文献46
-
1王鸣和,王骏.缺血性心肌病的研究近况[J].国际心血管病杂志,2007,34(1):1-5. 被引量:28
-
2Masson S, Laniti R, Ananod IS, et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patientswith chronic and symptomatic heart failure: the Valsartan" Heart Failure (Val-HeFT) data[ J]. Clin Chem, 2006, 52(8) :1528-1538.
-
3Kolesnikova AV, Ivleva Ala, Lagatina OE, et al. Clinical value of brain natriuretie peptide level in patients with atrial fibrillation[J]. Kardioloqiia, 2011,51 (6) :32-37.
-
4Iwanaga Y, Nishi I, Furuichi S, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure [ J ]. J Am Coil Cardiol, 2006,47(4) :742-748.
-
5白梅,杨杰孚.非瓣膜病心房颤动患者血清biT-proBNP水平及β受体阻滞剂干预[D].北京:中国协和医科大学,2007.
-
6Vaas B, de Ruijter W, Gussekloo J, et al. The accuracy of plasma natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic heart failure in community-dwelling eldly: a systematic re- view[J]. Age Ageing, 2009,38(6) :655-662.
-
7Huang BS, Ahmad M, Tan J, ,et al. Sympathetic hyperactivity and cardiac dysfunction post - M1 : different impact of specific CNS versus general AT1 receptor blockade[ J]. J Mol Cell Cardiol,2007,43:479 -486.
-
8Panagopoulou V, Deftereos S, Kossyvakis C, et al. NTproBNP: an important biomarker in cardiac diseases [ J ]. Curr Top Med Chem, 2013,13 (2) :82 - 94.
-
9Helme Silvet,Lee Ann Hawkins,Alan K. Jacobson.Heart Rate Control in Patients With Chronic Atrial Fibrillation and Heart Failure[J].Congestive Heart Failure.2012(1)
-
10John W. Eikelboom,Stuart J. Connolly,Peggy Gao,Ernesto Paolasso,Raffaele De Caterina,Steen Husted,Martin O’Donnell,Salim Yusuf,Robert G. Hart.Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease[J].Journal of Stroke and Cerebrovascular Diseases.2012(6)
引证文献7
-
1洪冰,王连环,林祥灿.慢性心力衰竭合并心房颤动患者血清脑钠肽水平变化及意义[J].山东医药,2013,53(32):52-54. 被引量:5
-
2刘丽丹,支晓阳,许伟莹,戈睿佗,吴鑫虎,林雪峰.心房纤颤对缺血性心肌病患者血浆NT-proBNP水平的影响[J].医学研究杂志,2014,43(5):113-115. 被引量:1
-
3阮景贤.利尿剂对老年慢性心力衰竭伴心房颤动患者的疗效观察[J].健康研究,2014,34(4):439-440.
-
4田晓培.分析慢性心力衰竭患者合并心房颤动的危险因素[J].中国实用医药,2016,11(13):53-54. 被引量:4
-
5杨鸿.慢性心衰患者心脏超声诊断参数价值研究[J].中西医结合心血管病电子杂志,2016,4(10):78-79. 被引量:7
-
6徐正云,任国珍.老年心力衰竭合并心房颤动病人血清NT-proBNP的临床意义[J].中西医结合心脑血管病杂志,2017,15(17):2157-2160. 被引量:22
-
7王生.慢性心力衰竭合并房颤患者血浆NT-proBNP水平的变化评价[J].心血管病防治知识(学术版),2019,9(4):50-51. 被引量:3
二级引证文献42
-
1邵丽.温阳强心方对心肾阳虚夹血瘀型慢性心衰患者血浆NT-proBNP水平及心功能的影响[J].湖北中医杂志,2020(5):7-9. 被引量:3
-
2章太炎.狱中赠邹容[J].中华活页文选(成人版),2000(6).
-
3朱智勇,杨江宁.慢性心力衰竭患者心脏超声诊断参数的临床价值[J].深圳中西医结合杂志,2018,28(21):12-14.
-
4张广建.托拉塞米配伍多巴胺对顽固性心衰患者氨基末端脑钠肽前体水平及心功能的影响[J].中国医学工程,2018,26(12):92-94. 被引量:4
-
5朱璞.活血化淤疗法在缺血性心肌病患者中应用价值分析[J].中外医疗,2015,34(7):169-170.
-
6田晓培.分析慢性心力衰竭患者合并心房颤动的危险因素[J].中国实用医药,2016,11(13):53-54. 被引量:4
-
7王萍.心房颤动合并心力衰竭患者实验室指标的变化及其意义[J].内科急危重症杂志,2016,22(3):204-205. 被引量:11
-
8杨鸿.慢性心衰患者心脏超声诊断参数价值研究[J].中西医结合心血管病电子杂志,2016,4(10):78-79. 被引量:7
-
9张利侠.慢性心力衰竭合并房颤者应用心理护理效果探析[J].中西医结合心血管病电子杂志,2016,4(20):133-133. 被引量:4
-
10李斌,黄瑛,刘兰.超声新技术在慢性心力衰竭心脏同步性检测中的临床应用价值[J].中国当代医药,2017,24(31):131-133. 被引量:2
-
1袁宝鸿.长期应用ACEI及β受体阻滞剂对收缩性心衰患者NT-proBNP及心功能的影响[J].浙江临床医学,2014,16(3):390-391. 被引量:4
-
2黄志民.血浆和肽素、B型利钠肽水平改变在慢性心力衰竭中的临床意义分析[J].吉林医学,2014,35(22):4902-4903. 被引量:2
-
3邵春来,洪小苏,陈建昌,高岚,徐卫亭,江建良.原发性高血压患者血浆利钠肽水平的变化[J].苏州大学学报(医学版),2005,25(1):101-103. 被引量:4
-
4蒲艳.血浆利钠肽水平与慢性心力衰竭的探讨[J].贵州医药,2004,28(10):879-881. 被引量:1
-
5朱海波,甘绍军,柳荫,黄瑞连.血浆B型利钠肽水平与慢性心力衰竭相关性观察[J].中国乡村医药,2009,16(7):13-13.
-
6贾红莉,杨黎明.无创通气治疗急性心肌梗死合并急性肺水肿临床分析[J].中西医结合心血管病电子杂志,2016,4(1):70-71. 被引量:1
-
7董春花,李永东.血浆B型利钠肽在急性心肌梗死中的研究进展[J].医学综述,2010,16(17):2664-2666.
-
8韩曼,于远望.利钠肽家族及其与心力衰竭的关系[J].海南医学,2015,26(17):2558-2561. 被引量:1
-
9丁宁,严义培,刘淑华.室间隔缺损患儿血浆脑钠素浓度与心功能关系的探讨[J].临床荟萃,2006,21(7):481-482.
-
10余玉兰,邵春来.慢性心衰患者步行试验前后血浆利钠肽变化的临床分析[J].齐齐哈尔医学院学报,2010,31(17):2747-2749.